IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
- PMID: 26353983
- DOI: 10.1136/gutjnl-2015-309903
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
Abstract
Background: Crohn's disease (CD) is a chronic disabling and progressive IBD. Only strategies looking beyond symptoms and based on tight monitoring of objective signs of inflammation such as mucosal lesions may have the potential for disease modification. Endoscopic evaluation is currently the gold standard to assess mucosal lesions and has become a major therapeutic endpoint in clinical trials. Several endoscopic indices have been proposed to evaluate disease activity; unvalidated and arbitrary definitions have been used in clinical trials for defining endoscopic response and endoscopic remission in CD.
Methods: In these recommendations from the International Organization for the Study of Inflammatory Bowel Disease, we first reviewed all technical aspects of available endoscopic scoring systems in the literature. Second, in order to achieve consensus on endoscopic definitions of remission and response in trials, a two-round vote based on a Delphi method was performed among 14 specialists in the field of IBDs.
Results: At the end of the voting process, the investigators ranked first a >50% decrease in Simple Endoscopic Score for Crohn's Disease (SES-CD) or Crohn's Disease Endoscopic Index of Severity for the definition of endoscopic response, and an SES-CD 0-2 for the definition of endoscopic remission in CD. All experts agreed on a Rutgeerts' score i0-i1 for the definition of endoscopic remission after surgery.
Keywords: CROHN'S DISEASE.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Similar articles
-
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.Gastroenterology. 2013 Nov;145(5):978-986.e5. doi: 10.1053/j.gastro.2013.08.010. Epub 2013 Aug 14. Gastroenterology. 2013. PMID: 23954314 Clinical Trial.
-
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.Aliment Pharmacol Ther. 2017 Mar;45(6):801-813. doi: 10.1111/apt.13948. Epub 2017 Jan 23. Aliment Pharmacol Ther. 2017. PMID: 28112419 Review.
-
Defining Endoscopic Remission in Ileocolonic Crohn's Disease: Let's Start from Scratch.J Crohns Colitis. 2018 Nov 9;12(10):1245-1248. doi: 10.1093/ecco-jcc/jjy097. J Crohns Colitis. 2018. PMID: 29982528
-
Definition and evaluation of mucosal healing in clinical practice.Dig Liver Dis. 2013 Dec;45(12):969-77. doi: 10.1016/j.dld.2013.06.010. Epub 2013 Aug 7. Dig Liver Dis. 2013. PMID: 23932331 Review.
-
Implementation of the simple endoscopic activity score in crohn's disease.Saudi J Gastroenterol. 2016 May-Jun;22(3):183-91. doi: 10.4103/1319-3767.182455. Saudi J Gastroenterol. 2016. PMID: 27184635 Free PMC article. Review.
Cited by
-
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease.J Crohns Colitis. 2022 May 10;16(4):616-624. doi: 10.1093/ecco-jcc/jjab183. J Crohns Colitis. 2022. PMID: 34664635 Free PMC article.
-
Impact of therapies on bowel damage in Crohn's disease.United European Gastroenterol J. 2020 May;8(4):410-417. doi: 10.1177/2050640620908696. Epub 2020 Feb 20. United European Gastroenterol J. 2020. PMID: 32213030 Free PMC article. Review.
-
Evolving therapeutic goals in Crohn's disease management.United European Gastroenterol J. 2020 Mar;8(2):133-139. doi: 10.1177/2050640619887316. Epub 2019 Nov 4. United European Gastroenterol J. 2020. PMID: 32213074 Free PMC article. Review.
-
Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis.World J Gastroenterol. 2021 May 28;27(20):2521-2530. doi: 10.3748/wjg.v27.i20.2521. World J Gastroenterol. 2021. PMID: 34092973 Free PMC article. Review.
-
Use of double-balloon endoscopy and an endoscopic scoring system to assess endoscopic remission in isolated small bowel Crohn's disease after treatment with infliximab.Therap Adv Gastroenterol. 2024 Jan 19;17:17562848231224842. doi: 10.1177/17562848231224842. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38250016 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical